Clinical Trials Directory

Trials / Completed

CompletedNCT01087047

Upper Airways in Pregnancy: Evaluation by the Acoustic Reflection Method

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Club d'Anesthésie-Réanimation Pédiatrique Armand Trousseau · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

It is well known that airway management can be difficult during pregnancy. Increased risks for difficult intubation in pregnant women have been often reported. Thus, pregnancy is regarded as a period of high anesthesiologic risk. Generalized weight gain is a well known factor influencing the upper airway in pregnant women. However, the modifications of the airway itself are less well documented. The acoustic reflection method is based on the analysis of the reflection of a single transient planar wave allowing the analysis of the longitudinal cross-sectional area profile of the examined cavity. It is a noninvasive and harmless method. The aim of the study is to evaluate by acoustic reflection method the physiological modifications of the upper airways during pregnancy. Women enrolled in the study will undergo an acoustic recording during the first, second, and third trimester of pregnancy, as well as two days and one month after delivery. Forty pregnant women will be included in this monocentric, prospective, open labelled study. Moreover, a single acoustic recording will be performed in 10 other pregnant women undergoing an MRI for obstetrical purpose. The estimated caliber of the upper airways by MRI and acoustic method will be compared.

Conditions

Interventions

TypeNameDescription
DEVICEAcoustic reflection methodAn acoustic reflection device gives the longitudinal cross-sectional area profile along airways. It is based on the analysis of a planar acoustic wave propagating in a rigid duct connected to airway.

Timeline

Start date
2010-03-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2010-03-15
Last updated
2012-06-12

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01087047. Inclusion in this directory is not an endorsement.